CORRECTING and REPLACING Millennium is #1 in Boston Globe Ranking of Top Largest Employer

  CORRECTING and REPLACING Millennium is #1 in Boston Globe Ranking of Top
  Largest Employer Millennium: The Takeda Oncology Company

Business Wire

CAMBRIDGE, Mass. -- November 05, 2012

Throughout the release, change references from "best large" to "top largest".

The corrected release reads:


Millennium: The Takeda Oncology Company today announced it has been named the
top largest employer in metropolitan Boston by the Boston Globe. This year,
Millennium ranked first among largest companies, overall, moving up from
second in 2011. The article appeared in the November 4, 2012 edition of the
Boston Sunday Globe.

“Being named the top largest employer in the Boston area is a tremendous
accomplishment for our Company, and a true reflection of the passion and
commitment that our employees have for their work – which is bringing hope to
people living with cancer,” said Deborah Dunsire, M.D., President and Chief
Executive Officer, Millennium.

The Boston Globe’s 2012 Top Places to Work survey was conducted by WorkPlace
Dynamics. The Globe invited 1,586 employers to participate in the survey; 304
organizations employing a total of 210,000 people completed the process.
Completed surveys were received from 81,907 individuals, who rated their
employers based on workplace practices in compensation, leadership,
appreciation, career opportunities and management.

To read the full article, please visit: and

About Millennium

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company
based in Cambridge, Mass., markets a first-in-class proteasome inhibitor, and
has a robust clinical development pipeline of product candidates. Millennium
Pharmaceuticals, Inc. was acquired by Takeda Pharmaceutical Company Ltd.
("Takeda", TSE: 4502) in May, 2008. The Company's research, development and
commercialization activities are focused in oncology. Additional information
about Millennium is available through its website,

Editor’s Note: This press release is also available under the Media section of
the Company’s website at:


Manisha Pai, 617-551-7877
Press spacebar to pause and continue. Press esc to stop.